Company / EPS (Diluted)
BIOCRYST PHARMACEUTICALS INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.21
FY2025
5-year range
-$1.33 / $1.21
FY2021-FY2025
Trend
+381.4%
vs FY2024
Sector context
#29 of 204
Health Care
What the data says
EPS (Diluted) changed +381% YoY in FY2025, a notable deviation from the 7-year average annual change of +52%.
Based on SEC 10-K filings.
1.21 in FY2025. Top quartile in the Health Care sector.
Improved from $-1.18 to $1.21 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 204This company $1.21 Sector average -$0.98
▼
+223.5% above sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 381.4% year-over-year.
- Ranks #29 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.21 | +381.4% |
| FY2024 | -$0.43 | +63.6% |
| FY2023 | -$1.18 | +11.3% |
| FY2022 | -$1.33 | -29.1% |
| FY2021 | -$1.03 | +5.5% |
| FY2020 | -$1.09 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -$0.59 | +13.2% |
| FY2016 | -$0.68 | -223.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026